ATX vs MVP

ASX Healthcare sector comparison — updated 3 Sep 2026 — Healthcare sector

ATX

AMPLIA FPO [ATX]

56MEDIUM

MVP

MEDICALDEV FPO [MVP]

62MEDIUM-HIGH

Score Breakdown

ATX MVP
Technical
52
68
Catalyst
50
50
Sentiment
50
50
Fundamental
68
95
Momentum
62
51
Risk Gate
50
50

Key Metrics

ATX Metric MVP
$69.3MMarket Cap$52.9M
779KAvg Volume (20d)214K
+0.0%Short InterestN/A
$0.27552-Week High$0.765
$0.10052-Week Low$0.365
+0.0%Daily Change+2.2%
$0.135Reference Price$0.460
-25.5%ROE+1.1%
-160.9%Profit Margin+1.5%

Active Signals

ATX Signals

RSI drifting toward oversold territory — worth watching
MACD momentum is losing steam
Stochastic is deep in oversold territory — bounce conditions forming
Sitting near support — this level has held before and could attract buyers again
Drifting lower — down 6.9% over the last 5 days
Volatility is contracting — like a spring being compressed, breakouts often follow
Below the 200-day average — the long-term trend is still working against it
Strong cash runway (13 quarters)

MVP Signals

Stochastic is deep in oversold territory — bounce conditions forming
Smart money may be accumulating — volume is flowing in even though price hasn't moved yet
Trading above the 200-day average — the long-term trend is on your side
Cash positive / operating cashflow positive
Low P/S ratio (1.2x)
Moderate revenue growth (+10%)
Piotroski F-Score strong (8/9, low-confidence approx)
EPS estimates revised upward (+10pts)

Ask Scout AI to compare ATX and MVP in depth.

Open Scout AI →

Track both stocks and 2,200+ more — Free

Daily AI-powered screening across every ASX small cap.

Open Screener

Related Comparisons

BLS vs CUV →BLS vs MVP →CGS vs IMM →CUV vs IIQ →CUV vs LDX →
ATX Full Analysis → MVP Full Analysis → Healthcare Sector → All Comparisons →
GENERAL INFORMATION ONLY. SmallCapData provides algorithmic screening data and does not constitute personal financial advice, a recommendation, or an offer to buy or sell any security. This content is produced by an algorithm, not a licensed financial adviser. You should consider seeking independent financial advice before making any investment decision. Past performance is not indicative of future results. Trading in small-cap securities carries a high degree of risk, including the risk of total loss of capital. The author may hold positions in mentioned securities. SmallCapData does not hold an Australian Financial Services Licence (AFSL).